People: Beluga Composites Corp (BGCC.PK)

BGCC.PK on OTC Markets Group - US Other OTC and Grey Market

0.00USD
18 Apr 2013
Price Change (% chg)

$-0.01 (-99.00%)
Prev Close
$0.01
Open
$0.00
Day's High
$0.00
Day's Low
$0.00
Volume
9,997
Avg. Vol
161
52-wk High
$0.01
52-wk Low
$0.00

Search Stocks

Summary

Name Age Since Current Position

John Kaiser

 60 1992 Chairman of the Board of Directors, President, Chief Executive Officer

James Welch

 54 1997 Vice President, Chief Financial Officer, Secretary, Treasurer

William Wright

 54 1995 Vice President - Operation

R. Green

 54 1996 Vice President - Quality Assurance and Regulatory Affairs

Robert Testorff

 55 1996 Vice President - Human Resources and Director Human Resources

Robert Curry

 63 1991 Director

Patrick Latterell

 48 1989 Director

David Rubinfien

 80 1990 Director
» Insider Trading

Biographies

Name Description

John Kaiser

 John Kaiser has served as President and Chief Executive Officer of the Company since April 1990 and as a Director since June 1990. In March 1992, he was appointed Chairman of the Board. From 1981 to 1990, Mr. Kaiser was employed by Boehringer Mannheim, GmbH, a multinational medical products corporation, where he most recently served as President of the Physician Laboratory Products Division. From 1970 to 1981, Mr. Kaiser was employed by Abbott Laboratories, a multinational medical products company, where he served in various positions including Business Unit Manager, Small Instruments Group and Marketing Manager, Noninfectious Diseases, of the diagnostics division. Mr. Kaiser has been a Director of Instrumentation Metrics, Inc. since December 1994. Mr. Kaiser holds a B.S. in Economics from the University of Wisconsin.

James Welch

 James H. Welch, was appointed Vice President and Chief Financial Officer in July 1997. He was most recently as Division Controller and from 1985 to 1988 he held various positions at Avantek, Inc., a telecommunications company, where his most recent position was a Senior Finance Manager. Mr. Welch received his M.B.A. from Washington State University and received his B.A. in Business Administration from Whitworth College.

William Wright

 William M. Wright III, joined Biocircuits as Vice President, Operations in November 1995. From 1984 to 1995, Mr. Wright was Vice President of Site Operations with Dade International Inc., a medical products manufacturing company. Mr. Wright received a B.S. in Industrial Technology from California State University at Long Beach.

R. Green

 R. Jeffrey Green, joined Biocircuits as Vice President, Quality Assurance and Regulatory Affairs in January 1996. From 1993 to 1995, Mr. Green was Department Head and Director of Quality Assurance and Regulatory Affairs for Sigma Diagnostics, a division of the Sigma Chemical Co. unit of Sigma-Aldrich Corp., a chemical company. From 1992 to 1993, Mr. Green was Vice President, Quality Assurance/Regulatory Affairs for the Dade Division of Baxter Diagnostics, Inc., a manufacturer of IN VITRO diagnostic reagents and analytical instrumentation; and from 1988 to 1992 he was Director, Quality and Regulatory Affairs for Smith & Nephew Inc./Dyonics, a manufacturer of medical products. Mr. Green received a B.S in Chemistry and Biology from the University of South Carolina.

Robert Testorff

 Robert D. Testorff, was appointed Vice President, Human Resources in November 1996. Mr. Testorff had served as Director, Human Resources since joining Biocircuits in February 1993. From 1990 to 1993, Mr. Testorff was employed as an organizational development consultant for Howard Consulting, serving clients in aerospace, biotechnology and software industries. From 1989 to 1990, he served as Director, Human Resources of Print Technology, a retail start-up. From 1985 to 1989, he worked for Bernard Hodes, an Ominicom Group Company, as a human resources management consultant for a variety of high technology clients in the Bay area and Los Angeles basin. From 1973 to 1985, Mr. Testorff was employed by Rockwell International where his last position was Director, Human Resources, Telecommunications Group. Other employment included Fairchild Industries. Mr. Testorff received a Juris Doctorate degree from Southern Methodist University School of Law and a B.S. in History/Political Science from Wichita State University.

Robert Curry

 Robert Curry, Ph.D., has served as a Director of the Company since May 1991. He has been a General Partner of the Sprout Group, a submanager of various Merrill Lynch venture capital funds, since May 1991, and is currently Vice President of DLJ Capital Corp., the management company for the Sprout Group. From August 1984 to May 1991, Dr. Curry was employed at ML Venture Capital, Inc., and ML R&D Management Inc., each a venture capital management company, most recently as President of both companies. Dr. Curry is a Director of Connective Therapeutics, Inc., Diatide, Inc. and Photon Technology International, Inc. Dr. Curry holds a Ph.D. and an M.S. in Analytical Chemistry from Purdue University and a B.S. in Physics from the University of Illinois. Dr. Curry is the chairman of the Compensation Committee and a member of the Disinterested Compensation Committee.

Patrick Latterell

 Patrick Latterell, has served as a Director of the Company since September 1989. Mr. Latterell is a General Partner of Venrock Associates, a venture capital investment group, which he joined in April 1989. Prior to joining Venrock Associates, Mr. Latterell was a Senior Vice President at Rothschild Ventures, Inc., a venture capital investment group, and a general partner of several affiliated venture capital partnerships. Mr. Latterell is a Director of Vical Inc., Pharmacyclics, Inc. and Geron Corporation. Mr. Latterell holds an M.B.A. from Stanford University and S.B. degrees in Biological Sciences and Economics from the Massachusetts Institute of Technology. Mr. Latterell is a member of the Audit Committee and the Disinterested Compensation Committee.

David Rubinfien

 David Rubinfien, has served as a Director of the Company since December 1990. From January 1989 to January 1991, Mr. Rubinfien was employed by Systemix, Inc., a biotechnology company, most recently as President, Chief Executive Officer and Chairman of the Board. From September 1985 to March 1989, he was Chairman and Chief Executive Officer of Microgenics Corporation, a biotechnology company. Mr. Rubinfien serves as a Director of Molecular Biosystems, Inc., ChemTrak Incorporated, and Matritech Inc. He holds an M.S. in Mathematics and Physics from the Illinois Institute of Technology and an M.B.A. from the University of Chicago. Mr. Rubinfien is a member of the Compensation Committee, the Disinterested Compensation Committee and became a member of the Audit Committee in May 1997.

Basic Compensation

Name Fiscal Year Total

John Kaiser

 222,157

James Welch

 --

William Wright

 178,898

R. Green

 --

Robert Testorff

 --

Robert Curry

 --

Patrick Latterell

 --

David Rubinfien

 --
As Of 30 Dec 1996

Options Compensation

Name Options Value

John Kaiser

 216,298 5,275

James Welch

 0 0

William Wright

 56,250 0

R. Green

 0 0

Robert Testorff

 0 0

Robert Curry

 0 0

Patrick Latterell

 0 0

David Rubinfien

 0 0

Insider Trading

» Full list on Insider Trading
Search Stocks